(redirected from VEGF)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
It was reported that thin endometrium pathophysiologic features were as follows: increased flow impedance of radial arteries has a detrimental effect on the glandular epithelium, leading to a decreased level of vascular endothelial growth factor (VEGF).
Western blot analysis showed that VEGF and NOS proteins were increased after diabetes induction (Figures 5(a)-5(d)).
Our method is as follows: (1) a mixture of VEGF primer probe + [H.sub.2]O + polymerase (at 5x concentration) was prepared.
In the same analysis, TMA histology was most frequently associated with VEGF-ligand targeted therapy (such as bevacizumab and aflibercept) suggesting two, possibly distinct pathophysiologies [37, 38] between renal damage caused by targeting the VEGF ligand as opposed to targeting the VEGFR tyrosine kinase domain.
The VEGF-R1 assay detected both cell surface VEGF receptor 1 as well as the circulating level of s-FLT-1.
The formation of new blood vessels necessitates VEGF, fibroblast growth factor, angiogenin, etcetera, which are modulated by HIF-1.9-11 HIF-1 is thought to be critical mediator of the transcriptional response to hypoxia and the expression of HIF-1a, the main activity unit, is regulated by oxygen availability.3,14
We conducted a retrospective study of a cross-sectional historical cohort to evaluate the expression of VEGF and COX-2 markers in SCC of the larynx or hypopharynx and to correlate their expression with tumor size.
The analysis of plasma IL-6 level was done on day 3, the VEGF analysis was done on day 5, and the observation of wound closure was done on days 3, 5, and 7.
Distribution of Renal Cell Carcinomas According to Histological Diagnoses and Expression of VEGF and Ki-67 in Various Sub-Types
In the period between first and second examination, significant changes were recorded in VEGF ([chi square]=4.65, df=1; p=0.031).
It is known that most eyes with AMD require long-term anti-VEGF treatment, and it is the constant neutralization of VEGF, which is crucial for ocular homeostasis, that may lead to adverse effects.